Beryl Capital Management LLC 13D/13G Filings for Albireo Pharma, Inc. (ALBO)

Beryl Capital Management LLC 13D and 13G filings for Albireo Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-02-27
4:05 pm
Purchase
2023-02-1613GAlbireo Pharma, Inc.
ALBO
Beryl Capital Management LLC1,483,599
7.100%
1,483,599increase
(New Position)
Filing